標(biāo)題: Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines [打印本頁(yè)] 作者: 可樂(lè) 時(shí)間: 2025-3-21 16:55
書(shū)目名稱Immunosuppression under Trial影響因子(影響力)
書(shū)目名稱Immunosuppression under Trial影響因子(影響力)學(xué)科排名
書(shū)目名稱Immunosuppression under Trial網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Immunosuppression under Trial網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Immunosuppression under Trial被引頻次
書(shū)目名稱Immunosuppression under Trial被引頻次學(xué)科排名
書(shū)目名稱Immunosuppression under Trial年度引用
書(shū)目名稱Immunosuppression under Trial年度引用學(xué)科排名
書(shū)目名稱Immunosuppression under Trial讀者反饋
書(shū)目名稱Immunosuppression under Trial讀者反饋學(xué)科排名
作者: GEON 時(shí)間: 2025-3-21 22:31 作者: Retrieval 時(shí)間: 2025-3-22 01:28
Minimal standards for reporting clinical trial results in transplantationbenefit of that therapy. Not all therapeutic decisions in medicine are based on the results of clinical trials. For example, insulin is the standard treatment of diabetic ketoacidosis, even though this therapy was never tested in a randomized controlled trial. Similarly, the need to use immunosuppre作者: 微枝末節(jié) 時(shí)間: 2025-3-22 06:42 作者: 傀儡 時(shí)間: 2025-3-22 09:33 作者: FILLY 時(shí)間: 2025-3-22 13:18 作者: 冷漠 時(shí)間: 2025-3-22 17:50
Factors influencing long-term allograft survival the steady attrition of transplanted organs due to chronic rejection. The UNOS published half-life for cadaveric renal allografts is approximately 8.5 years, not significantly different from the 7.7 year half-life published for cadaveric renal allografts under azathioprine-prednisone immunosuppress作者: hair-bulb 時(shí)間: 2025-3-22 23:40 作者: progestogen 時(shí)間: 2025-3-23 04:57
Cardiovascular complications after renal transplantation than 49.2% by death with a functioning graft, while other causes account for a further 9.4%. Thus, reduction of cardiovascular death will be a very efficient measure to preserve grafts. According to the EDTA Registry [2], the frequency of death from cardiovascular causes increases markedly with age作者: EXCEL 時(shí)間: 2025-3-23 06:28
Strategies to minimize nephrotoxicity associated to calcineurin inhibitorsclosporine and tacrolimus has been reported [1–3]. Mihatsch et al. [4] found that the side effect pattern of these drugs is nearly identical: they were unable to differentiate morphological changes associated with their clinical nephrotoxicity.作者: 記憶 時(shí)間: 2025-3-23 11:06
Diabetogenic effect of immunosuppressive drugst toxic effect on islet beta cells, or an indirect effect, such as insulin resistance. The problem of immunosuppression-induced diabetes is clinically relevant because patients may develop long-term degenerative complications related to glucose intolerance or suffer a deterioration of their quality 作者: troponins 時(shí)間: 2025-3-23 14:04 作者: 非實(shí)體 時(shí)間: 2025-3-23 21:23 作者: Expurgate 時(shí)間: 2025-3-24 00:19
rst edition of Clinical Applications of Cognitive Therapy was published in 1990, it provided a valuable resource for practitioners, researchers, and advanced students of Cognitive Therapy. At that time, a large body of research supported the cognitive view of psychopathology and showed that Cognitiv作者: 亞當(dāng)心理陰影 時(shí)間: 2025-3-24 05:14 作者: maudtin 時(shí)間: 2025-3-24 07:42
C. Legendrey a solid grounding in principles while modeling an integrative approach to the problems they will encounter most. The same quartet of knowledgeable clinicians who authored the original have updated and restructured their work to take readers through the best of contemporary cognitive practice, from作者: 向外 時(shí)間: 2025-3-24 13:43 作者: manifestation 時(shí)間: 2025-3-24 17:10 作者: 身心疲憊 時(shí)間: 2025-3-24 19:47 作者: HUMP 時(shí)間: 2025-3-24 23:33 作者: callous 時(shí)間: 2025-3-25 04:44 作者: micronized 時(shí)間: 2025-3-25 11:10
M. Antoineal Phobia, Panic Disorder with Agoraphobia, Paranoia, Schizophrenia, Major Depression, and ordinary shyness. What distinguishes Avoidant Personality Disorder from these other disorders, according to DSM-III-R, is that the social withdrawal of Avoidant Personality Disorder is due to per-vasive social作者: 優(yōu)雅 時(shí)間: 2025-3-25 13:31
al Phobia, Panic Disorder with Agoraphobia, Paranoia, Schizophrenia, Major Depression, and ordinary shyness. What distinguishes Avoidant Personality Disorder from these other disorders, according to DSM-III-R, is that the social withdrawal of Avoidant Personality Disorder is due to per-vasive social作者: 打火石 時(shí)間: 2025-3-25 18:49 作者: 絕種 時(shí)間: 2025-3-25 22:19 作者: Mhc-Molecule 時(shí)間: 2025-3-26 01:54
P. Moons,S. Fairchild,S. De Geest of the investigators who have tested, during the last few years, the hypo- thesis that continuous infusion chemotherapy could modulate the cytotoxic effect of radiation therapy to the point of having a strongly additive, if not synergistic activity on certain malignant tumors. This volume represent作者: LAVE 時(shí)間: 2025-3-26 05:19 作者: A保存的 時(shí)間: 2025-3-26 10:13
J. Alsinan of hematopoietic cytokines into the clinical practice of oncology represents one of the more interesting recent examples of technologic innovation translating into clinical therapeutics. The corporate-sponsored research that tested these recombinant agents in humans set new standards for rapidly t作者: 輕信 時(shí)間: 2025-3-26 13:14 作者: Hemiplegia 時(shí)間: 2025-3-26 19:09
Z. A. Massy(BM) play a central role in regulating haemopoiesis. Despite considerable research efforts, the precise molecular mechanisms responsible for this control remain to be fully defined. Nevertheless, from these studies has emerged the general consensus that at least two classes of molecules including ha作者: 減至最低 時(shí)間: 2025-3-26 23:15
B. T?nshoff,O. Mehls,L. Webern of hematopoietic cytokines into the clinical practice of oncology represents one of the more interesting recent examples of technologic innovation translating into clinical therapeutics. The corporate-sponsored research that tested these recombinant agents in humans set new standards for rapidly t作者: Fester 時(shí)間: 2025-3-27 03:13
NA technology has provided the opportunity to obtain many of the benefits of blood transfusion without transfusing blood .. Although inventory concerns have always made blood conservation a priority of Transfusion Medicine specialists, after the introduction of the lethal retrovirus HIV into the blo作者: lattice 時(shí)間: 2025-3-27 09:03
Conference proceedings 1999velopment. In order to contribute to the design offuture strategies, a critical approach of surrogate endpoints is givenand long-term side effects are analysed, together with the impact ofnon-compliance, quality-of-life and economical parameters. In thisbook, international specialists have set up th作者: FIS 時(shí)間: 2025-3-27 12:07 作者: Obverse 時(shí)間: 2025-3-27 13:51 作者: Electrolysis 時(shí)間: 2025-3-27 21:45
Patients’ appraisal of side effects in quality of life assessments of immunosuppressive regimensf complications and mortality rate provides a more sophisticated and balanced view of treatment effects. Quality of life data offer a more complete understanding of the benefit/burden ratio associated with medical treatments in terms of patients’ physical, emotional/mental and social functioning.作者: ungainly 時(shí)間: 2025-3-28 00:20
Conference proceedings 1999 analysed, together with the impact ofnon-compliance, quality-of-life and economical parameters. In thisbook, international specialists have set up the scientific rationaleand provided new bases for further immunosuppressive strategies.作者: Initiative 時(shí)間: 2025-3-28 02:16 作者: frivolous 時(shí)間: 2025-3-28 06:54 作者: crucial 時(shí)間: 2025-3-28 12:17
Diabetogenic effect of immunosuppressive drugsorders of glucose metabolism may also enhance complications induced by some other metabolic abnormalities found in transplant recipients, such as atherosclerosis and disorders in lipid metabolism. The diabetic state can decompensate or accelerate cardiovascular complications, which is a leading cause of patient death after transplantation.作者: 橢圓 時(shí)間: 2025-3-28 16:22 作者: Colonnade 時(shí)間: 2025-3-28 19:20 作者: zonules 時(shí)間: 2025-3-29 00:52
e under development. In order to contribute to the design offuture strategies, a critical approach of surrogate endpoints is givenand long-term side effects are analysed, together with the impact ofnon-compliance, quality-of-life and economical parameters. In thisbook, international specialists have作者: mercenary 時(shí)間: 2025-3-29 04:31 作者: Abutment 時(shí)間: 2025-3-29 08:29 作者: 碎石頭 時(shí)間: 2025-3-29 12:58
Can we minimize long-term side effects of immunosuppressive drugs on lipid metabolism?Hyperlipidemia (also referred to as dyslipidemia) is common after solid organ transplantation. It has been reported in more than 60% of heart [1], kidney [2, 3], and lung transplant recipients [4], as well as in more than 30% of liver transplant recipients [5, 6].作者: 殺蟲(chóng)劑 時(shí)間: 2025-3-29 18:13
Transplantation and Clinical Immunologyhttp://image.papertrans.cn/i/image/462291.jpg作者: myocardium 時(shí)間: 2025-3-29 19:50 作者: Blasphemy 時(shí)間: 2025-3-30 02:30
The success of clinical immunosuppressive trials in heart transplantation: the early detection of acar cells which may also be seen passing through the vessel walls in the myocardium. The infiltration is focal but progresses and increases in intensity. The development of more severe acute rejection is associated with interstitial edema and myocyte necrosis. The grading of cellular rejection has been standardized by Billingham (Table 1).作者: CUMB 時(shí)間: 2025-3-30 07:31 作者: Paradox 時(shí)間: 2025-3-30 08:51
https://doi.org/10.1007/978-94-011-4643-2cancer; clinical trial; immunosuppression; kidney; transplantation作者: 假裝是我 時(shí)間: 2025-3-30 12:49 作者: PTCA635 時(shí)間: 2025-3-30 19:18
Cardiovascular complications after renal transplantation The survival advantage conferred by transplantation is well illustrated by the studies of Port et al. [4] and Bonal et al. [5]. The relative mortality of graft recipients beyond the first month after transplantation was substantially lower, particularly in diabetic patients [4] and high risk elderl作者: Atheroma 時(shí)間: 2025-3-31 00:09 作者: 嚴(yán)厲譴責(zé) 時(shí)間: 2025-3-31 03:49 作者: abject 時(shí)間: 2025-3-31 07:25
